tert-Butyl N-(5-aminooxan-3-yl)carbamate

Catalog No.: 
ACPFYW932
CAS No.: 
1422772-85-7
Molecular Formula: 
C10H20N2O3
Molecular Weight: 
216.28
tert-Butyl N-(5-aminooxan-3-yl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25mg97%$117.00In stockInquiry
50mg97%$199.00In stockInquiry
100mg97%$337.00In stockInquiry
250mg97%$670.00In stockInquiry
1g97%$1342.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl N-(5-aminooxan-3-yl)carbamate
IUPAC Nametert-butyl (5-aminotetrahydro-2H-pyran-3-yl)carbamate
MDL No.MFCD28717398
Molecular FormulaC10H20N2O3
Molecular Weight216.28
SMILESO=C(OC(C)(C)C)NC1COCC(N)C1
InChI KeyFPXGQHKETFWNEP-UHFFFAOYSA-N
Synonymtert-butyl (5-aminotetrahydro-2H-pyran-3-yl)carbamate;tert-butyl N-(5-aminooxan-3-yl)carbamate
CAS No.1422772-85-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACPFYW932 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPFYW932 route product structure diagram
    ACPFYW9321422772-85-7In Stock
Inquiry

2. ACPFYW932 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACPFYW932 route product structure diagram
    ACPFYW9321422772-85-7In Stock
Inquiry

3. ACPFYW932 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPFYW932 route product structure diagram
    ACPFYW9321422772-85-7In Stock
Inquiry

Comments (0)